Clinical Laboratory Services Market share research by applications and regions for 2017-2024

Escalating need for reduced healthcare spending and early detection of chronic ailments will push Clinical laboratory services market expansion. Acceptance of new laboratory techniques to deliver effective and accurate clinical results along with substantial amounts of lab automation in developed nations is expected to favorably impact the business growth. Strategies such as mergers & acquisitions are expected to play a key role in influencing the clinical laboratory services market trends. For instance, in April 2017, MGRC (Malaysian Genomics Resource Centre Bhd) had declared that it will acquire 50% of the shares of the MPath Sdn Bhd firm. This will help the former focus more on the development of clinical testing, genetic screening, molecular diagnostic testing, and medical lab services. In addition, MGRC has also planned to build two new pathology laboratories near the east coast of peninsular Malaysia by the end of 2017 to focus on improving its pathological services.

Rising old population prone to contagious diseases and cardiac & neurological disorders will result in high requirement for screening & diagnostic tests, thereby creating huge market demand. According to Global Market Insights, Inc., “Clinical laboratory services industry revenue is slated to hit USD 342.3 billion by 2024, registering a CAGR of 6.4% over the coming seven years.”

Request sample copy @ https://www.gminsights.com/request-sample/detail/807

Hospitals, clinics, and standalone laboratories are the major providers of clinical laboratory services. Hospital-based laboratories, which contributed to more than USD 113 billion towards clinical laboratory services market revenue in 2015, is expected to significantly boost the industry size in future. Standalone laboratories sector, which contributed to more than USD 73 billion towards the clinical laboratory services industry revenue in 2015, is set to record a CAGR of 7% over the coming timeframe. The growth can be credited to the capability of the labs to handle a wide range of tests and offer real time delivery.

Considering the regional trends, Europe clinical laboratory services industry is projected to surpass USD 62 billion by 2024, driven by high awareness regarding disease prevention through extensive use of advanced diagnostic tests for early disease detection. UK and Germany are likely to be the key revenue drivers of clinical laboratory services market across the region.

Asia Pacific clinical laboratory services market is expected to hit the revenue margin of USD 76 billion by 2024, subject to implementation of stringent regulatory norms favoring the application of medical laboratory services coupled with the huge presence of geriatric population susceptible to the chronic ailments & infections. Large-scale infrastructural development complemented by the introduction of new diagnostic techniques along with the rising popularity of healthcare IT systems across the region will boost clinical laboratory services industry revenue. Japan, China, and India are projected to drive the regional share.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/807

U.S. clinical laboratory services industry, which contributed more than USD 64 billion in North America market in 2015, is anticipated to witness a notable expansion over the years to come. The growth of clinical laboratory services industry can be attributed to the rising acceptance of modern robot assisted lab techniques such as TECAN liquid handling robotics along with improved presence of big test volumes.

Human & tumor genetics, medical microbiology & cytology, clinical chemistry, and other esoteric tests are the major tests carried out in medical laboratories across the globe. Clinical chemistry, which accounted for more than 47% of clinical laboratory services market share in 2015, is projected to surpass USD 152 billion by 2024. Clinical laboratory services industry expansion from clinical chemistry sector can be credited to the rising occurrence of liver, heart, kidney, blood, and diabetes disorders, along with the increasing patient awareness about the benefits of disease diagnosis during the initial stages.

XIFIN Incorporation, a reputed healthcare information technology firm involved in healthcare diagnostics business, has declared a partnership deal with PWNHealth LLC, a virtual care firm providing access to diagnostic testing and professional guiding services. As per the deal, XIFIN can promote PWN’s services, supplementing its connected health services such as comprehensive billing service for diagnostic service providers. The deal will help XIFIN in fulfilling the growing consumer demand for diagnostic testing and will help to serve them better. This will allow the firm to achieve a competitive advantage in the thriving healthcare information technology sector via the creation of compelling services portfolio, thereby boosting the business development. In addition, the transaction will produce lucrative growth avenues for XIFIN customers and encourage them to introduce new services across the healthcare sector.

Market participants will try to enhance their geographical presence through mergers & acquisitions, high R&D investments, technological innovations, and product differentiations. Major players had captured 45% of clinical laboratory services industry share in 2015. Quest Diagnostics Incorporation, LabCorp, Genoptix Medical Laboratory, Sonic Healthcare Limited, Charles River Laboratories Incorporation, Spectra Laboratories, Bioscientia Healthcare Group, Siemens AG, Sanofi Genzyme, Abbott Laboratories, Healthscope Limited, Qiagen, Bio-Reference Laboratories Incorporation, and Labco S.A. are the key participants of clinical laboratory services industry.

Report Content

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.1.1. Initial data exploration

1.1.2. Statistical modeling and forecast

1.1.3. Industry insights and validation

1.2. Data Sources

Chapter 2. Executive Summary

2.1. Clinical Laboratory Services 3600 synopsis, 2012 - 2024

2.1.1. Business trends

2.1.2. Regional trends

2.1.3. Product trends

Chapter 3. Clinical Laboratory Services Industry Insights

3.1. Industry segmentation

3.2. Industry Size and forecast, 2012 - 2024

3.3. Industry Impact forces

3.3.1. Growth drivers

3.3.1.1. Growing global geriatric population base

3.3.1.2. Increasing prevalence of target diseases

3.3.1.3. Introduction of innovative solutions

3.3.1.4. Rising demand for early disease detection

3.3.2. Industry pitfalls & challenges

3.3.2.1. Presence of ambiguous regulatory framework

3.4. Growth potential analysis

3.5. Porter’s analysis

3.6. Company Market Share Analysis, 2015

3.6.1 Strategy dashboard

3.7 PESTEL analysis

Chapter 4. Clinical Laboratory Services Market, Test Type Insights

4.1 Clinical laboratory services market share, by test type, 2015 & 2024

4.2 Human & Tumor Genetics

4.2.1 Market estimates by region, 2012 – 2024 (USD billion)

4.3 Clinical Chemistry

4.3.1 Market estimates by region, 2012 – 2024 (USD billion)

4.4 Medical Microbiology & Cytology

4.4.1 Market estimates by region, 2012 – 2024 (USD billion)

4.5 Other Esoteric Tests

4.5.1 Market estimates by region, 2012 – 2024 (USD billion)

Chapter 5. Clinical Laboratory Services Market, Service Provider Insights

5.1 Clinical laboratory services market share, by service provider, 2015 & 2024

5.2 Hospital-Based Laboratories

5.2.1 Market estimates by region, 2012 – 2024 (USD billion)

5.3 Stand-Alone Laboratories

5.3.1 Market estimates by region, 2012 – 2024 (USD billion)

5.4 Clinic-Based Laboratories

5.4.1 Market estimates by region, 2012 – 2024 (USD billion)

Chapter 6. Clinical Laboratory Services, Regional Insights

6.1. Clinical laboratory services market share, by region, 2015 & 2024

6.2. North America clinical laboratory services market

6.2.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.2.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.2.3. U.S.

6.2.3.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.2.3.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.2.4. Canada

6.2.4.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.2.4.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.3. Europe clinical laboratory services market

6.3.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.3.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.3.3. Germany

6.3.3.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.3.3.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.3.4. UK

6.3.4.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.3.4.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.4. Asia Pacific clinical laboratory services market

6.4.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.4.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.4.3. China

6.4.3.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.4.3.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.4.4. Japan

6.4.4.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.4.4.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.5. LATAM clinical laboratory services market

6.5.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.5.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.5.3. Brazil

6.5.3.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.5.3.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.5.4. Mexico

6.5.4.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.5.4.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.6. MEA clinical laboratory services market

6.6.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.6.2. Market estimates by service provider, 2012 – 2024 (USD billion)

6.6.3. South Africa

6.6.3.1. Market estimates by test type, 2012 – 2024 (USD billion)

6.6.3.2. Market estimates by service provider, 2012 – 2024 (USD billion)

Chapter 7. Company Profiles

7.1. Abbott Laboratories

7.1.1. Business Overview

7.1.2. Financial Data

7.1.3. Product Landscape

7.1.4. Strategic Outlook

7.2. ARUP Laboratories (Associated Regional & University Pathologists Inc.)

7.2.1. Business Overview

7.2.2. Financial Data

7.2.3. Product Landscape

7.2.4. Strategic Outlook

7.3. Bio-Reference Laboratories

7.3.1. Business Overview

7.3.2. Financial Data

7.3.3. Product Landscape

7.3.4. Strategic Outlook

7.4. Bioscientia Healthcare

7.4.1. Business Overview

7.4.2. Financial Data

7.4.3. Product Landscape

7.4.4. Strategic Outlook

7.5. Charles River Laboratories, Inc.

7.5.1. Business Overview

7.5.2. Financial Data

7.5.3. Product Landscape

7.5.4. Strategic Outlook

7.6. Clarient, Inc.

7.6.1. Business Overview

7.6.2. Financial Data

7.6.3. Product Landscape

7.6.4. Strategic Outlook

7.7. Genoptix Medical Laboratory

7.7.1. Business Overview

7.7.2. Financial Data

7.7.3. Product Landscape

7.7.4. Strategic Outlook

7.8. Genzyme

7.8.1. Business Overview

7.8.2. Financial Data

7.8.3. Product Landscape

7.8.4. Strategic Outlook

7.9. Healthscope Ltd.

7.9.1. Business Overview

7.9.2. Financial Data

7.9.3. Product Landscape

7.9.4. Strategic Outlook

7.10. Labco S.A

7.10.1. Business Overview

7.10.2. Financial Data

7.10.3. Product Landscape

7.10.4. Strategic Outlook

7.11. Laboratory Corporation Of America Holdings (LabCorp)

7.11.1. Business Overview

7.11.2. Financial Data

7.11.3. Product Landscape

7.11.4. Strategic Outlook

7.12. Qiagen

7.12.1. Business Overview

7.12.2. Financial Data

7.12.3. Product Landscape

7.12.4. Strategic Outlook

7.13. Quest Diagnostics

7.13.1. Business Overview

7.13.2. Financial Data

7.13.3. Product Landscape

7.13.4. Strategic Outlook

7.14. Siemens

7.14.1. Business Overview

7.14.2. Financial Data

7.14.3. Product Landscape

7.14.4. Strategic Outlook

7.15. Sonic Healthcare Ltd.

7.15.1. Business Overview

7.15.2. Financial Data

7.15.3. Product Landscape

7.15.4. Strategic Outlook

7.16. Spectra Laboratories

7.16.1. Business Overview

7.16.2. Financial Data

7.16.3. Product Landscape

7.16.4. Strategic Outlook

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.